Better Coronavirus Stock: Inovio Pharmaceuticals vs. Novavax
The race is on. Multiple drugmakers are rushing to test experimental antiviral drugs and vaccines that could treat or prevent the coronavirus and the disease that it causes, COVID-19. It's too early to know which companies will be successful, but a few of them appear to have promising coronavirus programs.
Two small biotechs that especially stand out are Inovio Pharmaceuticals (NASDAQ: INO) and Novavax (NASDAQ: NVAX). Which of these stocks is the better pick for investors? Here's how Inovio and Novavax compare.
Image source: Getty Images.
Source Fool.com
